🇺🇸 Norephrine in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 10
Most-reported reactions
- Blood Chloride Increased — 1 report (10%)
- Blood Glucose Increased — 1 report (10%)
- Blood Potassium Decreased — 1 report (10%)
- Blood Sodium Increased — 1 report (10%)
- Blood Urea Increased — 1 report (10%)
- Hepatitis C — 1 report (10%)
- Loss Of Consciousness — 1 report (10%)
- Oedema Peripheral — 1 report (10%)
- Pancreatitis — 1 report (10%)
- Platelet Count Increased — 1 report (10%)
Other Other approved in United States
Frequently asked questions
Is Norephrine approved in United States?
Norephrine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Norephrine in United States?
Institute of Liver and Biliary Sciences, India is the originator. The local marketing authorisation holder may differ — check the official source linked above.